Ypsomed Holding AG logo

YPSN - Ypsomed Holding AG Share Price

CHF160.4 -0.6  -0.4%

Last Trade - 14/04/21

Mid Cap
Market Cap £1.60bn
Enterprise Value £1.75bn
Revenue £318.0m
Position in Universe 324th / 1046
Unlock YPSN Revenue
Relative Strength (%)
1m +1.54%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -1.11%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
306.6 336.9 389.6 466.1 453.8 393.9 438.8 484.6 +5.1%
+76.2 +63.1 +22.2 +13.9 +17.3 -82.0 +169.8 +53.8
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 September 2020, YpsomedHolding AG revenues increased 5% to SF199.3M. Net incomedecreased 14% to SF6.5M. Revenues reflect Delivery Systemssegment increase of 19% to SF108.3M. Net income was offsetby Other Operating Income decrease of 67% to SF2.3M(income), Foreign Exchange Gain decrease of 64% to SF1.1M(income). Basic Earnings per Share excluding ExtraordinaryItems decreased from SF0.60 to SF0.52.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


YPSN Revenue Unlock YPSN Revenue

Net Income

YPSN Net Income Unlock YPSN Revenue

Normalised EPS

YPSN Normalised EPS Unlock YPSN Revenue

PE Ratio Range

YPSN PE Ratio Range Unlock YPSN Revenue

Dividend Yield Range

YPSN Dividend Yield Range Unlock YPSN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
YPSN EPS Forecasts Unlock YPSN Revenue
Profile Summary

Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.

Last Annual March 31st, 2020
Last Interim September 30th, 2020
Incorporated December 30, 2003
Public Since September 22, 2004
No. of Shareholders: 6,238
No. of Employees: 1,800
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange SIX Swiss Exchange
Shares in Issue 12,602,953
Free Float (0.0%)
Eligible for
YPSN Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for YPSN
Upcoming Events for YPSN
Wednesday 26th May, 2021
Full Year 2021 Ypsomed Holding AG Earnings Call
Frequently Asked Questions for Ypsomed Holding AG
What is the Ypsomed Holding AG share price?

As of 14/04/21, shares in Ypsomed Holding AG are trading at CHF160.4, giving the company a market capitalisation of £1.60bn. This share price information is delayed by 15 minutes.

How has the Ypsomed Holding AG share price performed this year?

Shares in Ypsomed Holding AG are currently trading at CHF160.4 and the price has moved by 28.8% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Ypsomed Holding AG price has moved by 0.64% over the past year.

What are the analyst and broker recommendations for Ypsomed Holding AG?

Of the analysts with advisory recommendations for Ypsomed Holding AG, there are there are currently 1 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Ypsomed Holding AG is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Ypsomed Holding AG next release its financial results?

Ypsomed Holding AG is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Ypsomed Holding AG dividend yield?

The Ypsomed Holding AG dividend yield is 0.12% based on the trailing twelve month period.

Does Ypsomed Holding AG pay a dividend?

Last year, Ypsomed Holding AG paid a total dividend of 0.2, and it currently has a trailing dividend yield of 0.12%. Looking ahead, Ypsomed Holding AG has not announced an ex-dividend date yet.

When does Ypsomed Holding AG next pay dividends?

Ypsomed Holding AG has yet to annouce their ex-dividend date. The historic dividend yield on Ypsomed Holding AG shares is currently 0.12%.

How do I buy Ypsomed Holding AG shares?

To buy shares in Ypsomed Holding AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Ypsomed Holding AG?

Shares in Ypsomed Holding AG are currently trading at CHF160.4, giving the company a market capitalisation of £1.60bn.

Where are Ypsomed Holding AG shares listed? Where are Ypsomed Holding AG shares listed?

Here are the trading details for Ypsomed Holding AG:

Country of listing: Switzerland
Exchange: SWX
Ticker Symbol: YPSN
What kind of share is Ypsomed Holding AG?

Based on an overall assessment of its quality, value and momentum, Ypsomed Holding AG is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Ypsomed Holding AG share price forecast 2021?

Shares in Ypsomed Holding AG are currently priced at CHF160.4. At that level they are trading at 5.17% premium to the analyst consensus target price of 0.00.

Analysts covering Ypsomed Holding AG currently have a consensus Earnings Per Share (EPS) forecast of 2.357 for the next financial year.

How can I tell whether the Ypsomed Holding AG share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ypsomed Holding AG. Over the past six months, the relative strength of its shares against the market has been 1.96%. At the current price of CHF160.4, shares in Ypsomed Holding AG are trading at 12.67% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Ypsomed Holding AG PE Ratio?

The Ypsomed Holding AG PE ratio based on its reported earnings over the past 12 months is 0.196k. The shares are currently trading at CHF160.4.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Ypsomed Holding AG?

Ypsomed Holding AG's management team is headed by:

Niklaus Ramseier - CFO
Willy Michel - NEC
Beat Maurer - SVP
Anton Kraeuliger - NVC
Simon Michel - CEO
Hans Lehmann - SVP
Ulrike Bauer - SVP
Eberhard Bauer - SVP
Frank Mengis - COO
Michael Zaugg - SVP
Paul Fonteyne - NED
Martin Munchbach - NED
Who are the major shareholders of Ypsomed Holding AG?

Here are the top five shareholders of Ypsomed Holding AG based on the size of their shareholding:

Family (Michel) Individual Investor
Percentage owned: 74.9% (9.48m shares)
Premier Miton European Opportunities Fund Mutual Fund
Percentage owned: 1.41% (179k shares)
Premier Asset Management Ltd Investment Advisor/Hedge Fund
Percentage owned: 1.41% (179k shares)
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund
Percentage owned: 1.02% (130k shares)
Statens Pensjonsfond Utland Mutual Fund
Percentage owned: 1.02% (130k shares)
Similar to YPSN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.